CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Post-admission Duties announcement: Fresenius Medical Care AG / Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 20.02.2024 / 17:02 CET/CEST Dissemination of a Post-admission Duties announcement according to Article 50 Para. 1, No. 2 WpHG transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Fresenius Medical Care AG has filed its report on Form 20-F for the 4th quarter and full year 2023 with the U.S. Securities and Exchange Commission (SEC). The report is available on the website https://www.freseniusmedicalcare.com/en/investors/publications   20.02.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	Fresenius Medical Care AG
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News	EQS News Service

1841313  20.02.2024 CET/CEST